Preview

FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 9, No 3 (2016) DRUGS PROVIDED TO BREAST CANCER PATIENTS WITHIN THE STATE PROGRAMS OF DRUG SUPPLY Abstract  similar documents
M. V. Avxentyeva, V. I. Bogin, E. V. Derkach, V. V. Omelyanovskiy, M. B. Stenina, A. V. Tarakanov, M. Yu. Frolov
"... on the antineoplastic agents (L01) and hormonal antineoplastic drugs (L02) dispensed through programs of drug supply ..."
 
Vol 11, No 3 (2018) What is the role of antineoplastic drug safety in reimbursement decision making? Abstract  similar documents
A. S. Kolbin, A. A. Kurylev
"... Rationale. From 2014 to 2017, the portion of antineoplastic drugs dossiers submitted ..."
 
Vol 12, No 4 (2019) Optimization of drug supply for patients with malignant neoplasms in a region of the Russian Federation Abstract  similar documents
A. V. Nikitina, F. V. Gorkavenko, Y. S. Saybel, M. V. Avxentyeva, M. S. Sura, D. V. Fedyaev
"... The aim was to assess the possibility of optimizing the costs of drugs for cancer patients ..."
 
Vol 8, No 2 (2015) PRINCIPLES OF IMPORT SUBSTITUTION REGARDING DRUGS Abstract  similar documents
Alana Viktorovna Dzaneva, Vitalii Vladimirovich Omel'yanovskii, Saniyat Aleksandrovna Kagermazova
"... This articles is devoted to major principles of import substitution regarding drugs within ..."
 
Vol 5, No 1 (2012) DYNAMICS OF PREFERENTIAL MAINTENANCE OF CITIZENS WITH ANTIHYPERTENSIVE DRUGS AT THE EXPENSE OF THE REGIONAL BUDGET Abstract  similar documents
I. I. Lavrentyeva, A. I. Khokhlov, I. N. Kagramanyan, T. A. Gorokhova
"... released antihypertensive drugs that are caused by decrease in average costof one prescription. ..."
 
Vol 12, No 2 (2019) Dynamics of prices and consumption of anticancer drugs in Russia after their generics and biosimilars became available Abstract  similar documents
F. V. Gorkavenko, A. V. Nikitina, E. S. Saibel’, M. V. Avksent’eva, M. V. Sura, D. V. Fedyaev
"... trends in the general picture of drug prices and consumption. In the present study, we analyze ..."
 
Vol 10, No 1 (2017) RESTRICTIVE LISTS OF DRUGS: REGULATIONS, FUNCTIONS, SOURCES OF FINANCE, AND GUIDELINES FOR CREATION Abstract  similar documents
M. V. Sura
"... and sources of finance pertaining to the restrictive lists of drugs, which play a substantial role in the drug ..."
 
Vol 7, No 4 (2014) ROAD MAP FOR DEVELOPMENT OF PRICE REGULATION SYSTEM AND SYSTEM OF DRUG SUPPLY AT THE EXPENSE OF RUSSIAN FEDERATION HEALTHCARE SYSTEM FUNDS Abstract  similar documents
M. V. Sura, K. V. Gerasimova, V. V. Omelyanovskiy, M. V. Avksentieva
"... study goal is to prepare a road map for development of price regulation system and system of drug ..."
 
Vol 12, No 4 (2019) Clinical and economic analysis of drug costs in a general hospital in 2014-2018 Abstract  similar documents
A. T. Burbello, A. S. Fedorenko, E. L. Latariya, M. V. Pokladova, K. A. Zagorodnikova
"... Objectives. To study the structure of drug purchases by a general hospital considering the names ..."
 
Vol 12, No 2 (2019) Health technology assessment and reimbursement of pharmaceuticals in Italy Abstract  similar documents
F. V. Gorkavenko, V. V. Omelyanovskiy, T. P. Bezdenezhnykh, G. R. Khachatryan
"... здравоохранения (ОТЗ), ответственным за решения о государственном возмещении стоимости лекарственных препаратов и ..."
 
Vol 7, No 3 (2014) ASSESSMENT OF NECESSARY FINANCIAL EXPENSES ON THE DRUG SUPPLY OF THE PATIENTS WITH ORPHAN DISEASES IN THE RUSSIAN FEDERATION Abstract  similar documents
M. V. Sura, K. V. Gerasimova, V. V. Omelyanovskiy, M. V. Avksentyeva
"... the article presents the results of cost calculation on the drug supply of the patients ..."
 
Vol 9, No 1 (2016) MATHEMATICAL MODEL OF REIMBURSEMENT DECISION MAKING IN RUSSIA. RESULTS OF VIM LIST FOR 2016 Abstract  similar documents
A. S. Kolbin, A. V. Prasolov, E. A. Maksimkina, Yu. E. Balykina, Z. M. Golant, Yu. S. Polushin, A. A. Kurylev, I. A. Vilyum
"... Background: In 2014 we firstly analyzed the formalized system (points and expert opinions) of drug ..."
 
Vol 10, No 4 (2017) THE INTERNATIONAL PRACTICE OF DRUG SUPPLY IN THE OUTPATIENT SEGMENT Abstract  similar documents
D. V. Lukyantseva, L. S. Mel’nikova, A. P. Tatarinov
"... The paper examines the international experience of drug supply and the risks faced by countries ..."
 
Vol 9, No 2 (2016) MANAGEMENT ASPECT OF THE PROBLEM OF NARCOTIC DRUGS USE Abstract  similar documents
S. Yu. Soboleva, A. V. Sobolev, I. A. Kaminskaya
"... The use of narcotic drugs in healthcare system nowadays is characterized by lawful aspects ..."
 
Vol 6, No 3 (2013) PHARMACOECONOMIC ANALYSIS OF NEUROPROTECTIVE DRUGS IN THE TREATMENT OF ACUTE DISORDERS OF CEREBRAL CIRCULATION Abstract  similar documents
A. Yu. Kulikov, I. Yu. Zinchuk
"... Based on meta-analysis dates found, that the effectiveness of neuroprotective drugs and placebo ..."
 
Vol 10, No 3 (2017) Review of the current approaches to the assessment of the drug innovative potential worldwide Abstract  similar documents
N. Z. Musina, V. K. Fedyaeva, V. V. Omel’yanovskii, G. R. Khachatryan, K. V. Gerasimova, V. A. Lemeshko, K. P. Konchits
"... A set of criteria for assessing the innovative potential of drugs (therapeutic value) have been ..."
 
Vol 12, No 3 (2019) Clinical and economic analysis as an instrument for harmonizing import substitution in the preferential segment of medicinal support Abstract  similar documents
E. V. Eliseeva , E. S. Maneeva , R. K. Goncharova , A. V. Kropotov
"... the qualitative and quantitative indicators of drug supply. Materials and methods. We used the official ..."
 
Vol 10, No 2 (2017) THE USE OF MULTI-CRITERIAL DECISION ANALYSIS (MCDA) FOR ESTIMATING THE THERAPEUTIC VALUE OF INNOVATIVE DRUGS Abstract  similar documents
V. K. Fedyaeva, V. V. Omelyanovskiy, N. Z. Musina, G. R. Khachatryan, O. I. Ivakhnenko
"... регулирования лекарственных препаратов (ЛП) и, в первую очередь, инновационных ЛП. Во многих странах в качестве ..."
 
Vol 7, No 4 (2014) IS RUSSIA READY FOR THE INTRODUCTION OF THE NATIONAL REFERENCE PRICING SYSTEM? Abstract  similar documents
V. V. Omelyanovskiy
"... the analysis of foreign pricing and drug supply public funding systems (or a so-called drug ..."
 
Vol 12, No 4 (2019) The health technology assessment system in Australia Abstract  similar documents
V. V. Omelyanovskiy, E. S. Saybel, T. P. Bezdenezhnykh, G. R. Khachatryan
"... by the federal budget. The drug evaluation process includes five stages: a review of general information about ..."
 
Vol 11, No 2 (2018) Pharmacoeconomic analysis of treatment with nilotinib as the second line therapy in patients with chronic myeloid leukemia Abstract  similar documents
N. A. Avxentyev, M. Yu. Frolov, A. S. Makarov
"... are registered in second-line, however only dasatinib is included in the government drug reimbursement program ..."
 
Vol 9, No 2 (2016) EVALUATION OF RATIONALITY OF EXPENSES ON TREATMENT OF SEVERE COMMUNITY-ACQUIRES PNEUMONIA IN MULTI-PROFILE HOSPITAL Abstract  similar documents
I. V. Demko, N. V. Gordeeva, E. N. Bochanova, N. I. Golovina, A. Yu. Kraposhina, I. A. Soloveva, E. A. Sobko, T. V. Gaygolnik, S. V. Chubarova
"... drug treatment and identification of frequency of the separate medicinal preparations. We have data ..."
 
Vol 11, No 3 (2018) Use of medications in children hospitalized with community-acquired pneumonia Abstract  similar documents
D. D. Siukaeva, I. A. Narkevich, V. N. Timchenko, O. D. Nemyatyh, N. A. Maslova
"... respiratory tract prevailed (32.20%). As for the medications, the category J drugs “Antimicrobials of systemic ..."
 
Vol 8, No 1 (2015) PAYMENT OF NEW EXPENSIVE TECHNOLOGIES IN HEALTH CARE ON THE BASIS OF RISKS -SHARING AGREEMENTS: POSSIBILITIES OF APPLICATION IN THE RUSSIAN FEDERATION Abstract  similar documents
L. S. Melnikova
"... are used in foreign countries at reimbursement of costs for public drug supply. The author estimates ..."
 
Vol 7, No 4 (2014) APPLICATION OF MULTIPLE-CRITERIA ANALYSIS FOR OPTIMIZATION OF FINANCING OF RARE DISEASES Abstract  similar documents
V. V. Omelyanovskiy, V. K. Fedyaeva, O. Yu. Rebrova
"... financing of rare disease drugs remains a serious problem for both foreign countries and our ..."
 
Vol 5, No 1 (2012) PHARMACOECONOMIC EVALUATION OF THE PROPHYLAXIS OF POSTSURGICAL INFECTIOUS INFLAMMATORY COMPLICATIONS OF COMBINED ANTIBIOTIC DRUGS AND CORTICOSTEROIDS IN OPHTHALMIC PRACTICE IN RUSSIAN FEDERATION Abstract  similar documents
V. G. Serpik, R. I. Yagudina
"... инфекционно-воспалительных осложнений препаратами Тобрадекс (тобрамицин + дексаметазон) и Комбинил-Дуо ..."
 
Vol 11, No 3 (2018) The concept of multi-criteria analysis of decision-making in the current system of health technology assessment in Russia Abstract  similar documents
V. V. Omelyanovsky, V. K. Fedyaeva, N. Z. Musina
 
Vol 8, No 2 (2015) REASONS FOR DIFFICULTY OF THE PHARMACOECONOMIC ANALYSIS FOR ORPHAN DRUGS. WAYS FOR SOLUTIONS Abstract  similar documents
Andrey Vladislavovich Pavlysh, Aleksei Sergeevich Kolbin, Roman Andreevich Gapeshin, Stanislav Mikhailovich Malyshev
"... Orphan drugs are used for treatment of rare life-threatening diseases. There is no universal ..."
 
Vol 9, No 2 (2016) METASTATIC COLORECTAL TREATMENT COSTS OF USING TARGETED DRUGS IN SECOND AND FURTHER LINES THERAPY Abstract  similar documents
N. A. Avxentyev, E. V. Derkach, E. A. Pyadushkina, M. D. Ter-Ovanesov
"... Targeted drugs are recommended for treatment of metastatic colorectal cancer. Second and further ..."
 
Vol 12, No 4 (2019) Pharmacoeconomic analysis of using cyclin-dependent kinase 4 and 6 inhibitors in the first line treatment of HR-positive HER2-negative advanced breast cancer Abstract  similar documents
N. A. Avxentyev, E. V. Lubennikova, M. Yu. Frolov
"... and ribociclib that are included in Vital and Essential Drug List (VEDL) in combination with letrozole in first ..."
 
Vol 7, No 4 (2014) ANALYSIS OF GOVERNMENT PROCUREMENTS OF MEDICINES APPLIED IN RARE DISEASES THERAPY Abstract  similar documents
D. V. Fedyaev, V. K. Fedyaeva, V. V. Omelyanovsky
"... the article presents the results of analysis of the state procurement of the drugs for rare ..."
 
Vol 9, No 2 (2016) PHARMACOECONOMIC ANALYSIS OF VESOMNI (SOLIFENACIN AND CONTROLLED RELEASE TAMSULOSIN) TREATMENT OF STORAGE SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA Abstract  similar documents
N. A. Avxentyev, M. Yu. Frolov
"... The aim of the current study is pharmacoeconomic evaluation of using combined drug Vesomni ..."
 
Vol 11, No 2 (2018) Pharmacoeconomic analysis of using typical and atypical antipsychotics in schizophrenia Abstract  similar documents
I. A. Vilyum, B. V. Andreev, M. A. Proskurin, Yu. E. Balykina
"... was increased to 24 months, this economic advantage of AA diminished, and the kA drugs had a lower CeR instead ..."
 
Vol 12, No 3 (2019) Pharmacoepidemiological analysis of antimicrobial therapy for burn injury in the hospital settings Abstract  similar documents
O. V. Zhukova, E. S. Nekaeva, E. S. Khoroshavina, E. A. Kozlova, Yu. A. Dudukina, I. Yu. Arefyev
"... ) analysis was used to evaluate the actual drug consumption based on the defined daily dose; DU90% (Drug ..."
 
Vol 9, No 3 (2016) CLINICAL AND ECONOMIC EVALUATION OF LACOSAMIDE IN PATIENTS WITH PARTIAL EPILEPSY Abstract  similar documents
E. A. Pyadushkina, M. Yu. Frolov
"... of the Russian Federation in three scenarios: Lacosamide as concomitant drug to standard therapy in comparison ..."
 
Vol 7, No 4 (2014) АNALYSIS OF PSYCHOTROPIC DRUG CONSUPTION FOR SCHIZOPHRENIA TREATMENT IN DIFFERENT TYPE HOSPITALS Abstract  similar documents
P. S. Nosova, O. V. Reshetko
"... the goal of our research was to carry out an analysis of psychotropic drug utilization used ..."
 
Vol 12, No 1 (2019) Evaluation of the clinical efficacy of anti-asthma pharmacotherapy in children using the software package based on the Fishburn method Abstract  similar documents
O. V. Zhukova, I. V. Nikiforova
"... for the distribution of drugs by levels of clinical efficacy” is presented. Conclusion. It has been shown ..."
 
Vol 10, No 4 (2017) IMPROVEMENT OF PRICE REGULATION FOR INNOVATIVE MEDICINES COVERED BY THE NATIONAL BUDGET Abstract  similar documents
V. A. Lemeshko, N. Z. Musina, V. K. Fedyaeva
"... The current approaches to the drug pricing commonly used worldwide allow for incorporating ..."
 
Vol 7, No 1 (2014) PHARMACOEPIDEMIOLOGY: FROM THEORY TO PRACTICE Abstract  similar documents
S. A. Rachina, R. S. Kozlov, Yu. A. Belkova
"... the use of and the effects of drugs in the whole population or in large groups of people in order ..."
 
Vol 9, No 2 (2016) PHARMACO-ECONOMIC ANALYSIS OF COST IN TERMS OF MAINTENANCE OF PREFERENTIAL MEDICINES PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE ON THE TERRITORY OF KRASNOYARSK REGION Abstract  similar documents
T. V. Gaygolnik, I. V. Demko, E. N. Bochanova, A. Yu. Kraposhina, N. V. Gordeeva, I. A. Soloveva
"... .7%) and Salmeterol/ Fluticasonum (11%). The nomenclature of International unlicensed name of the drugs which ..."
 
Vol 10, No 2 (2017) COSTS OF ANTIRETROVIRAL DRUGS USED IN THE THERAPY OF HIV-INFECTED PATIENTS: A PHARMACOECONOMIC ANALYSIS Abstract  similar documents
M. B. Kubaeva, Y. Sh. Guchshina
"... of anti-HIV drugs. Material and methods. The study was based on the documented medical histories of HIV ..."
 
Vol 10, No 4 (2017) INTERNATIONAL APPROACHES TO THE GOVERNMENT PRICE CONTROL OVER GENERICS AND BIOSIMILARS: A REVIEW Abstract  similar documents
D. G. Tolkacheva, A. V. Torgov, A. S. Margazova
"... of the reviewed countries have policies controlling prices for generic drugs and employ the internal reference ..."
 
Vol 10, No 4 (2017) INTERNATIONAL APPROACHES TO THE GOVERNMENT PRICE CONTROL OVER GENERICS AND BIOSIMILARS: A REVIEW Abstract  similar documents
D. G. Tolkacheva, A. V. Torgov, A. S. Margazova
"... of the reviewed countries have policies controlling prices for generic drugs and employ the internal reference ..."
 
Vol 10, No 1 (2017) EVALUATION OF DRUG THERAPY IN PROGRESSING DIFFERENTIATED THYROID CANCER REFRACTORY TO RADIOACTIVE IODINE IN PATIENTS RESIDING IN THE RUSSIAN FEDERATION : PHARMACOECONOMIC ASPECTS Abstract  similar documents
M. Yu. Frolov, V. A. Rogov
"... aspects) drug for the treatment of widespread progressing differentiated thyroid cancer (DTC) refractory ..."
 
Vol 10, No 1 (2017) THE USE OF QALY AS AN INTEGRAL MEASURE OF EFFECTIVENESS IN THE EVALUATION OF MEDICAL TECHNOLOGIES Abstract  similar documents
N. Z. Musina, V. K. Fedyaeva
"... of QALY as a measure of drug effectiveness is not yet possible because of the lack of standardized ..."
 
Vol 11, No 3 (2018) Pharmacoeconomic analysis of using belimumab for the treatment of systemic lupus erythematosus Abstract  similar documents
A. G. Tolkushin, N. L. Pogudina
"... from analysis of published clinical and observational studies. The prices of the relevant drugs were ..."
 
Vol 11, No 4 (2018) Clinical and economic studies on pharmacotherapy of malignant neoplasms: the modeling approach Abstract  similar documents
A. G. Tolkushin, S. K. Zyryanov, N. L. Pogudina, M. V. Davydovskaya
"... drugs). The possibility of analyzing indirect and non-medical costs is also discussed. A dynamic version ..."
 
Vol 6, No 3 (2013) PHARMACOECONOMIC ANALYSIS OF DOCETAXEL IN THE ADJUVANT THERAPY OF BREAST CANCER Abstract  similar documents
R. I. Yagudina, I. Yu. Zinchuk
"... it was determined that for 10-years horizon cost rate for the treatment of one patient with breast cancer will be 1 ..."
 
Vol 10, No 3 (2017) The strategies of drug supply for patients with chronic hepatitis C Abstract  similar documents
E. V. Kornilova, A. D. Ermolaeva, M. G. Rusanova, D. A. Andreev, M. V. Davydovskaya, T. N. Ermolaeva, A. g Pokatilo, K. I. Polyakova, V. A. Dubovtseva, K. А. Kokushkin, A. V. Devyatkin
"... The report reviews the options of drug supply for patients with chronic hepatitis C in the Russian ..."
 
Vol 11, No 4 (2018) Treatment of patients with malignant lymphoproliferative diseases in the Russian Federation: analysis of the data from 75 regions Abstract  similar documents
G. R. Hachatryan, T. S. Teptsova, V. A. Lemeshko, N. Z. Musina
"... . Among the malignant LPDs, the highest costs of drug therapy in 2016 pertained to lymphosarcoma ..."
 
1 - 50 of 146 Items 1 2 3 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)